Carl Zeiss Meditec (AFX) Given a €68.00 Price Target by Berenberg Bank Analysts

Share on StockTwits

Berenberg Bank set a €68.00 ($79.07) price objective on Carl Zeiss Meditec (ETR:AFX) in a report published on Monday. The brokerage currently has a neutral rating on the stock.

Other equities analysts have also recently issued research reports about the stock. Deutsche Bank set a €71.00 ($82.56) price target on shares of Carl Zeiss Meditec and gave the company a neutral rating in a research report on Tuesday, December 11th. Kepler Capital Markets set a €62.00 ($72.09) price objective on shares of Carl Zeiss Meditec and gave the company a sell rating in a research note on Tuesday, January 15th. Hauck & Aufhaeuser set a €78.50 ($91.28) price objective on shares of Carl Zeiss Meditec and gave the company a buy rating in a research note on Thursday, December 13th. Nord/LB set a €86.00 ($100.00) price objective on shares of Carl Zeiss Meditec and gave the company a buy rating in a research note on Monday, January 21st. Finally, Commerzbank set a €58.00 ($67.44) price objective on shares of Carl Zeiss Meditec and gave the company a neutral rating in a research note on Tuesday, November 27th. Three analysts have rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company’s stock. Carl Zeiss Meditec has a consensus rating of Hold and an average target price of €72.31 ($84.08).

Shares of ETR AFX opened at €80.95 ($94.13) on Monday. Carl Zeiss Meditec has a fifty-two week low of €37.53 ($43.64) and a fifty-two week high of €55.25 ($64.24).

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

See Also: Bear Market

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply